Study first to pinpoint why analgesic drugs may be less potent in females than in males

December 23, 2008

ATLANTA -- Investigators at Georgia State University's Neuroscience Institute and Center for Behavioral Neuroscience are the first to identify the most likely reason analgesic drug treatment is usually less potent in females than males. This discovery is a major step toward finding more effective treatments for females suffering from persistent pain.

"Opioid-based narcotics (such as morphine) are the most widely prescribed therapeutic agents for the alleviation of persistent pain; however, it is becoming increasingly clear that morphine is significantly less potent in women compared with men. Until now, the mechanism driving the phenomenon was unknown," said Anne Murphy, Ph.D., a Georgia State Professor of Neuroscience and member of the Center for Behavioral Neuroscience, who conducted the research with Dayna Loyd, Ph.D.

Murphy recently solved the mystery with findings printed in the December issue of The Journal of Neuroscience that show that previously reported differences in morphine's ability to block pain in male versus female rats are most likely due to sex differences in mu-opioid receptor expression in a region of the brain called the periaqueductal gray area (PAG).

Located in the midbrain area, the PAG plays a major role in the modulation of pain by housing a large population of mu-opioid receptor expressing neurons. Morphine and similar drugs bind to these mu-opioid receptors analogous to a 'lock and key' and, ultimately, tell the brain to stop responding to pain signals to the nerve cells resulting in the reduced sensation of pain.

Using a series of anatomical and behavioral tests, Murphy and Loyd were able to determine that male rats have a significantly higher level of mu-opioid receptors in the PAG region of the brain compared with females. This higher level of receptors is what makes morphine more potent in males because less drug is required to activate enough receptors to reduce the experience of pain. Interestingly, when they used a plant-derived toxin to remove the mu-opioid receptor from the PAG, morphine no longer worked, suggesting that this brain region is required for opiate-mediated pain relief.

Additional tests also found females reacted differently to morphine depending on the stage of their estrous cycle. These findings indicate that steroid hormones may affect mu-opioid receptor levels in the region of the PAG that are essential for analgesia and also suggest that the actions of morphine are estrous stage-dependent.

"Interestingly, sex is not the only factor that has been shown to affect the potency of various pharmacological agents. Recent studies have reported an influence of age and ethnicity, and further argue for the inclusion of a wide range of study subjects in pain management research," Murphy said. "In addition, despite the rapidly mounting evidence regarding the limitations of opiates in treating persistent pain, opioid-based drugs remain the primary pharmacological tool for pain management. Clearly additional research with the inclusion of female subjects needs to be devoted to determining a more potent treatment for persistent pain in women."

Georgia State University

Clinical Drug Data, 11th Edition (Handbook of Clinical Drug Data)
by Kelly Smith (Author), Daniel M. Riche (Author), Nickole Henyan (Author)

The best single resource available for evaluating and comparing more than 1200 commonly-used medications 4 STAR DOODY'S REVIEW!
"Although the primary audience for this book is practicing pharmacists, clinical pharmacists, pharmacy residents, and pharmacy students, the wide range of audiences who may benefit from this book include physicians and medical residents who may find this a useful resource, especially with the downloadable option....This is a useful and easy to use reference. Information is systematically organized in an easy to retrieve way."--Doody's Review Service "...will be useful to all health care professionals in a clinical setting." - Review of an earlier edition from the Australian Journal of Hospital Pharmacy Now includes PDA download of the...

NMDA antagonists as potential analgesic drugs (Progress in Inflammation Research)
by Dalip J.S. Sirinathsinghji (Editor), Ray G. Hill (Editor)

There is now considerable preclinical evidence that glutamate acting via the NMDA receptor is involved in the transmission of nociceptive information and in the triggering mechanisms for hyperalgesia and allodynia. This evidence allows rational development of a new class of analgesic drugs that act as antagonists of the NMDA receptor, supported by emerging evidence with existing excitatory amino acid antagonists. Leading scientists in excitatory amino acid and analgesia research have compiled in this volume the most recent information on molecular biology, physiology and pharmacology of NMDA receptors, their neuroanatomical localisation within specific neural pathways involved in nociception, and experimental and clinical evidence demonstrating the potential of receptor antagonists of...

Prescription Painkillers: History, Pharmacology, and Treatment (Library of Addictive Drugs)
by Marvin D Seppala M.D. (Author), Mark E. Rose M.A. (Author)

In recent years, the media has inundated us with coverage of the increasing abuse of prescription painkillers.

Prescription Painkillers, the third book in Hazelden's Library of Addictive Drugs series, offers current, comprehensive information on the history, social impact, pharmacology, and addiction treatment for such commonly abused, highly addictive opiate prescription painkillers as Oxycontin, Vicodin, Percocet, and Darvocet.

Dr. Marvin Seppala, chief medical officer at Hazelden Foundation, provides context for understanding the current drug abuse problem by tracing the history and their varying patterns of use over time. He then offers an in-depth study of the controversial issues surrounding these readily available drugs as over-prescription by physicians and...

Analgesic Drugs
by PARKHOUSE (Author)

Agonist and antagonist actions of narcotic analgesic drugs
by H. W.; Collier, H. O. J.; Villarreal, J. E. Kosterlitz (Author)

Oxycodone & OxyContin (Drugs 101)
by William Gladden Foundation Press

This concise summary of "need-to-know" information about oxycodone and OxyContin answers these important questions. What Is Oxycodone? What Are Some Brand Names Of Oxycodone? What Dangers Are Associated With Using Oxycodone? Who Should Not Take Oxycodone? Why Should Pregnant And Nursing Women Avoid Taking Oxycodone? Can A Person Overdose On Oxycodone? What Are Some Less Serious Effects Of Oxycodone? What Is OxyContin? How Does OxyContin Differ From Oxycodone? Is OxyContin Addictive? How Does OxyContin Work? What Are Street Names For OxyContin? What Are Withdrawal Symptoms Of OxyContin? What Are Symptoms of OxyContin Overdose? Who Can Help Oxycodone and OxyContin Abusers Quit?

Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care
by Rosemary R. Berardi (Author), Stefanie P. Ferreri (Author), Anne L. Hume (Author), Lisa A. Kroon (Author), Gail D. Newton (Author)

Thoroughly updated and revised, the Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 16th edition, helps students and practitioners develop problem-solving skills needed to assess and triage a pharmacy patient s medical problems. It provides U.S. Food and Drug Administration-approved dosing information and evidence-based research on the efficacy and safety of over-the-counter and herbal medications.
Key Features:
Contributors include more than 70 academics and practitioners from multiple health care fields with expertise in non-prescription medications and devices and other self-care options.
Updated information and references and new, improved anatomical drawings are included.
An enhanced complementary and alternative medicine section provides...

Saunders Handbook of Veterinary Drugs: Small and Large Animal, 3e (Handbook of Veterinary Drugs (Saunders))
by Mark G. Papich DVM MS DACVCP (Author)

Concise and easy-to-use, Saunders Handbook of Veterinary Drugs, 3rd Edition helps you find the specific drug facts you need to treat small and large animals, right when you need them! 550 drugs are organized alphabetically and cross-referenced by functional classification, trade, and generic names so you can access dosage recommendations, contraindications, side effects, possible adverse reactions, drug interactions, and more without the need to sort through a lengthy text. Plus, a companion website provides more than 150 clear, customizable handouts to help you easily communicate important drug information to your clients. All drug monographs are conveniently organized and cross-referenced to give you fast, easy access to key information for each drug, including: Generic and trade...

Drugs and the Kidney (New Clinical Applications: Nephrology)
by G.R. Catto (Editor)

Plant Bioactives and Drug Discovery: Principles, Practice, and Perspectives (Wiley Series in Drug Discovery and Development)
by Valdir Cechinel-Filho (Author)

An in-depth exploration of the applications of plant bioactive metabolites in drug research and developmentHighlighting the complexity and applications of plant bioactive metabolites in organic and medicinal chemistry, Plant Bioactives and Drug Discovery: Principles, Practice, and Perspectives provides an in-depth overview of the ways in which plants can inform drug research and development. An edited volume featuring multidisciplinary international contributions from acclaimed scientists researching bioactive natural products, the book provides an incisive overview of one of the most important topics in pharmaceutical studies today.With coverage of strategic methods of natural compound isolation, structural manipulation, natural products in clinical trials, quality control, and more, and...